TY - STD TI - International Society for Pharmacoeconomics and Outcomes Research: ISPOR global health care systems road map. Germany – Pharmaceuticals. [http://www.ispor.org/htaroadmaps/Germany.asp] UR - http://www.ispor.org/htaroadmaps/Germany.asp ID - ref1 ER - TY - STD TI - International Society For Pharmacoeconomics and Outcomes Research: ISPOR global health care systems road map. England – Pharmaceuticals. [http://www.ispor.org/htaroadmaps/UK.asp] UR - http://www.ispor.org/htaroadmaps/UK.asp ID - ref2 ER - TY - STD TI - Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung. [http://www.gesetze-im-internet.de/bundesrecht/sgb_5/gesamt.pdf] UR - http://www.gesetze-im-internet.de/bundesrecht/sgb_5/gesamt.pdf ID - ref3 ER - TY - STD TI - Directions and Consolidating Directions to the National Institute for Health and Clinical Excellence (from the Secretary of State for Health). [http://www.nice.org.uk/niceMedia/pdf/DirectionFromSecretaryOfState2005.pdf] UR - http://www.nice.org.uk/niceMedia/pdf/DirectionFromSecretaryOfState2005.pdf ID - ref4 ER - TY - STD TI - National Institute for Health and Care Excellence: Guidance for Manufacturers and Sponsors. The Technology Appraisals Process Series No. 5. [http://www.nice.org.uk/niceMedia/pdf/technicalguidanceformanufacturersandsponsors.pdf] UR - http://www.nice.org.uk/niceMedia/pdf/technicalguidanceformanufacturersandsponsors.pdf ID - ref5 ER - TY - STD TI - European Commission (Enterprise and Industry): Pharmaceuticals in Europe: Facts and Figures. [http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/importance/facts-figures_en.htm] UR - http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/importance/facts-figures_en.htm ID - ref6 ER - TY - STD TI - Verordnung über die Nutzenbewertung von Arzneimitteln nach § 35a Absatz 1 SGB V für Erstattungsvereinbarungen nach § 130b SGB V (Arzneimittel-Nutzenbewertungsverordnung – AM-NutzenV). [http://www.gesetze-im-internet.de/bundesrecht/am-nutzenv/gesamt.pdf] UR - http://www.gesetze-im-internet.de/bundesrecht/am-nutzenv/gesamt.pdf ID - ref7 ER - TY - STD TI - Beschluss des Gemeinsamen Bundesausschusses über die Einfügung eines Kapitels zur Bewertung des Nutzens von Arzneimitteln mit neuen Wirkstoffen nach § 35a SGB V in die Verfahrensordnung. [?], [http://www.g-ba.de/downloads/39-261-1273/2011-01-20_VerfO_35a_BAnz.pdf] UR - http://www.g-ba.de/downloads/39-261-1273/2011-01-20_VerfO_35a_BAnz.pdf ID - ref8 ER - TY - STD TI - IQWiG: Allgemeine Methoden 4.0. [https://www.iqwig.de/download/General_Methods_4-0.pdf] UR - https://www.iqwig.de/download/General_Methods_4-0.pdf ID - ref9 ER - TY - STD TI - IQWiG: Sich beteiligen an der Arbeit des IQWiG. [https://www.iqwig.de/de/sich_beteiligen.2949.html] UR - https://www.iqwig.de/de/sich_beteiligen.2949.html ID - ref10 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c332 DO - 10.1136/bmj.c332 ID - Schulz2010 ER - TY - JOUR AU - Des Jarlais, D. C. AU - Lyles, C. AU - Crepaz, N. PY - 2004 DA - 2004// TI - Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement JO - Am J Publ Health VL - 94 UR - https://doi.org/10.2105/AJPH.94.3.361 DO - 10.2105/AJPH.94.3.361 ID - Des Jarlais2004 ER - TY - JOUR AU - Von Elm, E. AU - Altman, D. G. AU - Egger, M. AU - Pocock, S. J. AU - Gøtzsche, P. C. AU - Vandenbroucke, J. P. PY - 2007 DA - 2007// TI - The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies JO - Ann Intern Med VL - 147 UR - https://doi.org/10.7326/0003-4819-147-8-200710160-00010 DO - 10.7326/0003-4819-147-8-200710160-00010 ID - Von Elm2007 ER - TY - JOUR AU - Kunz, R. AU - Vist, G. E. AU - Oxman, A. D. PY - 2007 DA - 2007// TI - Randomisation to protect against selection bias in healthcare trials JO - Cochrane Database Syst Rev VL - 2 ID - Kunz2007 ER - TY - JOUR AU - Glenny, A. M. AU - Altman, D. G. AU - Song, F. AU - Sakarovitch, C. AU - Deeks, J. J. AU - D'Amico, R. AU - Bradburn, M. AU - Eastwood, A. J. PY - 2005 DA - 2005// TI - Indirect comparisons of competing interventions JO - Health Technol Assess VL - 9 UR - https://doi.org/10.3310/hta9260 DO - 10.3310/hta9260 ID - Glenny2005 ER - TY - JOUR AU - Lu, G. AU - Ades, A. E. PY - 2004 DA - 2004// TI - Combination of direct and indirect evidence in mixed treatment comparisons JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1875 DO - 10.1002/sim.1875 ID - Lu2004 ER - TY - JOUR AU - Caldwell, D. M. AU - Ades, A. E. AU - Higgins, J. P. PY - 2005 DA - 2005// TI - Simultaneous comparison of multiple treatments: combining direct and indirect evidence JO - BMJ VL - 331 UR - https://doi.org/10.1136/bmj.331.7521.897 DO - 10.1136/bmj.331.7521.897 ID - Caldwell2005 ER - TY - JOUR AU - Salanti, G. AU - Higgins, J. P. T. AU - Ades, A. E. AU - Ioannidis, J. P. PY - 2008 DA - 2008// TI - Evaluation of networks of randomized trials JO - Stat Methods Med Res VL - 17 UR - https://doi.org/10.1177/0962280207080643 DO - 10.1177/0962280207080643 ID - Salanti2008 ER - TY - STD TI - The evaluation of surrogate endpoints. Springer, New York; 2005. ID - ref19 ER - TY - JOUR AU - Molenberghs, G. AU - Burzykowski, T. AU - Alonso, A. AU - Assam, P. AU - Tilahun, A. AU - Buyse, M. PY - 2010 DA - 2010// TI - A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials JO - Stat Methods Med Res VL - 19 UR - https://doi.org/10.1177/0962280209105015 DO - 10.1177/0962280209105015 ID - Molenberghs2010 ER - TY - JOUR AU - Weir, C. J. AU - Walley, R. J. PY - 2006 DA - 2006// TI - Statistical evaluation of biomarkers as surrogate endpoints: a literature review JO - Stat Med VL - 25 UR - https://doi.org/10.1002/sim.2319 DO - 10.1002/sim.2319 ID - Weir2006 ER - TY - STD TI - IQWiG: Glossar zu den Allgemeinen Methoden 3.0. Version 1.0. [https://www.iqwig.de/download/Glossar_Version_1_0_zu_den_Allgemeinen_Methoden_Version_3_0.pdf] UR - https://www.iqwig.de/download/Glossar_Version_1_0_zu_den_Allgemeinen_Methoden_Version_3_0.pdf ID - ref22 ER - TY - STD TI - IQWiG: Rapid Report: Aussagekraft von Surrogatendpunkten in der Onkologie. Version 1.0. [https://www.iqwig.de/download/A10-05_Rapid_Report_Version_1-1_Surrogatendpunkte_in_der_Onkologie.pdf] UR - https://www.iqwig.de/download/A10-05_Rapid_Report_Version_1-1_Surrogatendpunkte_in_der_Onkologie.pdf ID - ref23 ER - TY - STD TI - Kleijnen S, Goettsch W, D’Andon A, Vitre P, George E, Goulden S, Osińska B, Rdzany R, Zawada R, Thirstrup S, Nagy B, Corbacho B: EUnetHTA JA WP5: Relative Effectiveness Assessment (REA) of Pharmaceuticals. Background review. Appendix. [http://www.eunethta.eu/outputs/final-version-background-review-relative-effectiveness-assessment] UR - http://www.eunethta.eu/outputs/final-version-background-review-relative-effectiveness-assessment ID - ref24 ER - TY - JOUR AU - Burzykowski, T. AU - Buyse, M. PY - 2006 DA - 2006// TI - Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation JO - Pharm Stat VL - 5 UR - https://doi.org/10.1002/pst.207 DO - 10.1002/pst.207 ID - Burzykowski2006 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Fransen, G. A. AU - Van Marrewijk, C. J. AU - Mujakovic, S. AU - Muris, J. W. AU - Laheij, R. J. AU - Numans, M. E. AU - de Wit, N. J. AU - Samsom, M. AU - Jansen, J. B. AU - Knottnerus, J. A. PY - 2007 DA - 2007// TI - Pragmatic trials in primary care: methodological challenges and solutions demonstrated by the DIAMOND-study JO - BMC Med Res Methodol VL - 7 UR - https://doi.org/10.1186/1471-2288-7-16 DO - 10.1186/1471-2288-7-16 ID - Fransen2007 ER - TY - JOUR AU - Freemantle, N. AU - Blonde, L. AU - Bolinder, B. AU - Gerber, R. A. AU - Hobbs, F. D. AU - Martinez, L. AU - Ross, S. PY - 2005 DA - 2005// TI - Real-world trials to answer real-world questions JO - Pharmacoeconomics VL - 23 UR - https://doi.org/10.2165/00019053-200523080-00001 DO - 10.2165/00019053-200523080-00001 ID - Freemantle2005 ER - TY - JOUR AU - Tunis, S. R. AU - Stryer, D. B. AU - Clancy, C. M. PY - 2003 DA - 2003// TI - Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.12.1624 DO - 10.1001/jama.290.12.1624 ID - Tunis2003 ER - TY - STD TI - National Institute for Health and Care Excellence: Guide to the Methods of Technology Appraisal. [http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9] UR - http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9 ID - ref30 ER - TY - STD TI - National Institute for Health and Care Excellence: Single Technology Appraisal (STA). Specification for manufacturer/sponsor submission of evidence. [http://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-technology-appraisal-guidance] UR - http://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-technology-appraisal-guidance ID - ref31 ER - TY - STD TI - National Institute for Health and Care Excellence: Guide to the single technology appraisal (STA) process. [http://www.nice.org.uk/media/913/06/Guide_to_the_STA-proof_6-26-10-09.pdf], [http://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/Guide-to-the-single-technology-appraisal-process.pdf] UR - http://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/Guide-to-the-single-technology-appraisal-process.pdf ID - ref32 ER - TY - STD TI - Centre for Review and Dissemination: Systematic reviews: CRD’s guidance for undertaking reviews in health care. [http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf] UR - http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf ID - ref33 ER - TY - JOUR AU - Halpern, M. T. AU - Luce, B. R. AU - Brown, R. E. AU - Geneste, B. PY - 1998 DA - 1998// TI - Health and economic outcomes modelling practices: a suggested framework JO - Value Health VL - 1 UR - https://doi.org/10.1046/j.1524-4733.1998.120131.x DO - 10.1046/j.1524-4733.1998.120131.x ID - Halpern1998 ER - TY - JOUR AU - Sculpher, M. AU - Fenwick, E. AU - Claxton, K. PY - 2000 DA - 2000// TI - Assessing quality in decision analytic cost effectiveness models JO - Pharmacoeconomics VL - 17 UR - https://doi.org/10.2165/00019053-200017050-00005 DO - 10.2165/00019053-200017050-00005 ID - Sculpher2000 ER - TY - STD TI - National Institute for Health and Care Excellence: Technology appraisal decisions. , [http://www.nice.org.uk/News/NICE-statistics] UR - http://www.nice.org.uk/News/NICE-statistics ID - ref36 ER -